Plus Therapeutics (PSTV)
(Delayed Data from NSDQ)
$1.67 USD
+0.07 (4.06%)
Updated Apr 25, 2024 02:37 PM ET
3-Hold of 5 3
C Value A Growth A Momentum A VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 4/25/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.70 |
Last EPS Surprise | 10.26% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -0.99 |
Next Year | -1.03 |
EPS (TTM) | -4.39 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 2.30M | 2.30M | 9.43M | 7.84M |
# of Estimates | 1 | 1 | 1 | 1 |
High Estimate | 2.30M | 2.30M | 9.43M | 7.84M |
Low Estimate | 2.30M | 2.30M | 9.43M | 7.84M |
Year ago Sales | 0.51M | 1.85M | 4.91M | 9.43M |
Year over Year Growth Est. | 350.98% | 24.32% | 91.94% | -16.86% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.25 | -0.99 | -1.03 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -0.25 | -0.25 | -0.99 | -1.03 |
High Estimate | -0.25 | -0.25 | -0.99 | -1.03 |
Low Estimate | -0.25 | -0.25 | -0.99 | -1.03 |
Year ago EPS | -2.10 | -0.59 | -4.24 | -0.99 |
Year over Year Growth Est. | 88.10% | 57.63% | 76.65% | -4.04% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.25 | -0.99 | -1.03 |
7 Days Ago | -0.25 | -0.25 | -0.99 | -1.03 |
30 Days Ago | -0.25 | -0.25 | -0.99 | -1.03 |
60 Days Ago | -0.25 | -0.25 | -0.99 | -1.03 |
90 Days Ago | -0.25 | -0.25 | -0.99 | -1.03 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.25 | -0.25 | -0.99 | -1.03 |
Zacks Consensus Estimate | -0.25 | -0.25 | -0.99 | -1.03 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.70 | -1.00 | -0.59 | -2.10 | NA |
Estimate | -0.78 | -0.58 | -1.91 | -2.10 | NA |
Difference | 0.08 | -0.42 | 1.32 | 0.00 | 0.25 |
Surprise | 10.26% | -72.41% | 69.11% | 0.00% | 1.74% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more